$72.6M in CY2024 Part D spend13.7M claims · 10.3M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Azithromycin used for?
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specifi....
Is there a generic for Azithromycin?
Yes. 47 ANDAs filed at FDA, 20 generic manufacturers currently shipping.
How much does my plan pay for Azithromycin?
Across 329 Part D plans, Azithromycin averages $0.243/unit (NADAC). Lowest available: $0.213/unit. Highest in distribution: $0.288/unit.
Is Azithromycin on the FDA shortage list?
Azithromycin has been discontinued by its manufacturer(s).
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.